The relaxant effects of calcitonin gene-related peptide (CGRP) on the 3rd branches of renal arteries obtained from stroke-prone spontaneously hypertensive rats (SHRSP) ,and Wistar-Kyoto rats (WKY) were investigated in vitro . CGRP elicited concentrationdependent relaxation, and the relaxant response was not affected by the mechanical removal of endothelium in either SHRSP or WKY. The CGRP-induced relaxant response was markedly greater in SHRSP than in WKY , whereas there was no significant difference in acetylcholine-induced relaxation, which was endothelium-dependent , between the two groups. Additionally, significantly enhanced reactivity to CGRP was also shown in spontaneously hypertensive rats compared to WKY; however , this reactivity was less than that observed in SHRSP.There were also no significant differences between WKY and SHRSP in the relaxation induced by forskolin, dibutyryl cyclic AMP, and 3-isobutyl-1-methylxanthine (IBMX). CGRP-induced relaxation was significantly potentiated in similar manner by the pretreatment with IBMX in both WKY and SHRSP.Incubation with glibenclamide (10-6 M) had no effect on CGRP-induced relaxation in either group, the WKY or the SHRSP. These results suggest that CGRP produces endothelium-independent relaxation in the small renal arteries in the rat, and that the increased CGRP-induced relaxant response found in SHRSP may not be associated with the altered vasodilation mediated by cyclic AMP , or with functional changes in ATP-sensitive potassium channels .
Introduction
Calcitonin gene-related peptide (CGRP) (Amara at al., 1982; Rosenfeld et al ., 1983) has potent vasodilatory effects (Brain et al., 1985; Haass et al., 1985; Marshall et al., 1986a; 1986b) . CGRP-like immunoreactivity and specific binding sites for CGRP have been demonstrated in blood vessels as well as in some regions of the heart (Gibbins et al ., 1985; Saito et al., 1986; Sigrist et al., 1986; Uddman et al., 1986; Del Bianco et al ., 1991; Franco-Cereceda, 1991 with this concentration of IBMX, although the onset of contraction became a little slow .
Effects of glibenclamide on CGRP-induced relaxation
After the arteries were incubated with 10-6 M glibenclamide for 20 min , the effect of CGRP was tested in both endothelium-intact and rubbed preparations from SHRSP and WKY .
However, the glibenclamide pretreatment had no effect on the CGRP-induced relaxation (Fig .   6 ). NA-induced contraction was not affected by the pretreatment of glibenclamide .
Discussion
This study demonstrated that CGRP induced potent relaxation in the 3rd branches of rat renal arteries via an endothelium-independent mechanism . It has been reported that CGRP did not require intact endothelium to produce relaxation of rat basilar (Nishimura et al ., 1992) , gastric, splenic, and hepatic arteries (Bratveit et al., 1991; ) . However, it has been shown that CGRP produced vasodilation of the rat aorta (Brain et al ., 1985; Kubota et al., 1985; Grace et al., 1987) and superior mesenteric artery (Bratveit et al ., 1991) in an endothelium-dependent manner. Prieto et at (1991) found that CGRP-induced relaxation of rat proximal epicardial coronary arteries was almost abolished by the removal of endothelium , whereas such relaxation in the distal intramyocardial arteries was not affected . Thus, CGRP-induced relaxation in the rat vasculature appears to show heterogeneous endothelium dependency.
An enhanced relaxant response to CGRP was observed in small renal arteries from SHR and SHRSP, compared to the response for WKY. Further, the enhancement of relaxation was greater in SHRSP than in SHR. It seemed likely that this enhancement might be related to the different levels of elevated blood pressure in SHR and SHRSP. Whether these alterations in hypertensive animal models are hereditary or are a secondary effect of hypertension remains to be elucidated. It has been reported that CGRP-induced relaxation of mesenteric vascular beds was not increased in 8-week-old SHR (Kawasaki et al., 1990a) ; this would suggest that the enhanced relaxation response to CGRP might be a secondary effect due to hypertension.
On the other hand, in deoxycorticosterone acetate (DOCA)-salt hypertensive rats, no such alteration was observed (Kawasaki et al., 1990b) , indicating that this change might be hereditary.
There is much evidence that the action of CGRP is mediated through the generation of cyclic AMP in endothelial and vascular smooth muscle cells (Edvinsson et al., 1985; Kubota et al., 1985; Hirata et al., 1988; Crossman et al., 1990; Edwards et al., 1991) . In the present study on small renal arteries from WKY and SHRSP, we found that the relaxant response to CGRP was significantly potentiated by IBMX, a phosphodiesterase inhibitor, in similar manner.
Thus, it is indicated that the relaxation induced by CGRP in these arteries are mediated by the elevation of cyclic AMP, although cyclic AMP level was not actually measured. Furthermore, there were no significant differences between WKY and SHRSP in relaxation responses to forskolin, dibutyryl cyclic AMP and IBMX. These results suggest that the increased CGRPinduced relaxation observed in SHRSP small renal arteries is unlikely to be due to the altered vasodilation mediated by cyclic AMP.
A recent study (Nelson, 1990) has demonstrated that CGRP relaxed rabbit mesenteric arteries by activating KATP-channels. Glibenclamide, a blocker of KATP-channels, was shown to have markedly attenuated the relaxation induced by CGRP, and single potassium channel activity was increased by CGRP. Furthermore, potassium channel activity was reportedly increased in carotid arteries from SHRSP (Miyata et al., 1990) . Therefore, it is necessary to identify whether the increased reactivity to CGRP of SHRSP small renal arteries was mediated by enhanced KATP-channel involvement. However, we found that pretreatment with glibenclamide had no influence on the effects of CGRP on these arteries in either group. Other investigators have also found that CGRP-induced relaxation did not involve the activation of KATP-channels (Prieto et al., 1991; Abdelrahman et al., 1992; Kageyama et al., 1993) . Thus, it seems reasonable to postulate that the activation of KATP-channels by CGRP, if it does occur, plays a minor role in CGRP-induced relaxant effects in rat small renal arteries. CGRP has been shown to be involved in non-adrenergic, non-cholinergic vasodilatory responses in the mesenteric resistance vessls of the rat (Kawasaki et al., 1988) . Further, marked decrease in the release of CGRP-like immunoreactive substance evoked by perivascular stimulation, and significant enhancement of relaxation in response to exogenously applied CGRP have been shown in the mesenteric vascular beds of aged SHR (Kawasaki et al., 1991) .
There has been no direct evidence so far reported for the release of CGRP from perivascular nerves in rat small renal arteries. However, radioimmunoassay has found that renal artery of rat contained abundant CGRP (Mulderry et al., 1985) , and immunohistochemical studies also revealed that CGRP immunoreactive nerve fibers were mainly observed surrounding blood vessels in the cortex and outer medulla of rat kidney (Geppetti et al., 1989) . Thus, it might be reasonable to speculate that if the release of CGRP from perivascular nerves was impaired in the renal vasculature of SHRSP, this might cause up-regulation of CGRP receptors in vascular smooth muscles, and hence enhance reactivity to exogenous CGRP.
In conclusion, this study demonstrated that CGRP-induced relaxation in rat small renal arteries was endothelium-independent. Increased reactivity to CGRP was shown in SHR and SHRSP; this seemed to be due to the up-regulation of CGRP receptors in vascular smooth muscle cells. However, further investigation is needed to elucidate the pathophysiological role played by CGRP in the regulation of renal circulation and in the pathogenesis and maintenance of hypertension in hypertensive animals
